Vaxart Inc. [NASDAQ: VXRT] loss -2.05% or -0.13 points to close at $6.22 with a heavy trading volume of 3357161 shares. The company report on May 7, 2021 that Vaxart Announces First Subject Enrolled in Phase 1b Norovirus Dose-Ranging Trial in Elderly Adults.
Study will evaluate safety and immunogenicity of oral norovirus vaccine in elderly population.
Norovirus represents a significant unmet need in the elderly — there currently is no approved vaccine.
It opened the trading session at $6.35, the shares rose to $6.45 and dropped to $6.22, the range by which the price of stock traded the whole day. The daily chart for VXRT points out that the company has recorded -2.81% loss over the past six months. However, it is still -178.92% lower than its most recent low trading price.
If we look at the average trading volume of 16.69M shares, VXRT reached to a volume of 3357161 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Vaxart Inc. [VXRT]:
H.C. Wainwright have made an estimate for Vaxart Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on August 12, 2020. While these analysts kept the previous recommendation, B. Riley FBR raised their target price to Buy. The new note on the price target was released on July 13, 2020, representing the official price target for Vaxart Inc. stock.
The Average True Range (ATR) for Vaxart Inc. is set at 0.82, with the Price to Sales ratio for VXRT stock in the period of the last 12 months amounting to 464.71. The Price to Book ratio for the last quarter was 4.07, with the Price to Cash per share for the same quarter was set at 1.34.
Trading performance analysis for VXRT stock
Vaxart Inc. [VXRT] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.53. With this latest performance, VXRT shares gained by 2.64% in over the last four-week period, additionally sinking by -2.81% over the last 6 months – not to mention a rise of 123.74% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for VXRT stock in for the last two-week period is set at 45.48, with the RSI for the last a single of trading hit 42.17, and the three-weeks RSI is set at 47.00 for Vaxart Inc. [VXRT]. The present Moving Average for the last 50 days of trading for this stock 6.50, while it was recorded at 6.56 for the last single week of trading, and 6.98 for the last 200 days.
Vaxart Inc. [VXRT]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Vaxart Inc. [VXRT] shares currently have an operating margin of -766.66. Vaxart Inc.’s Net Margin is presently recorded at -796.34.
Return on Total Capital for VXRT is now -35.02, given the latest momentum, and Return on Invested Capital for the company is -38.23. Return on Equity for this stock declined to -47.26, with Return on Assets sitting at -33.98. When it comes to the capital structure of this company, Vaxart Inc. [VXRT] has a Total Debt to Total Equity ratio set at 17.94. Additionally, VXRT Total Debt to Total Capital is recorded at 15.21, with Total Debt to Total Assets ending up at 14.51. Long-Term Debt to Equity for the company is recorded at 14.02, with the Long-Term Debt to Total Capital now at 11.89.
Reflecting on the efficiency of the workforce at the company, Vaxart Inc. [VXRT] managed to generate an average of -$1,150,714 per employee. Receivables Turnover for the company is 2.05 with a Total Asset Turnover recorded at a value of 0.04.Vaxart Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 15.10 and a Current Ratio set at 15.10.
Vaxart Inc. [VXRT]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Vaxart Inc. posted -0.12/share EPS, while the average EPS was predicted by analysts to be reported at -0.06/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -100.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for VXRT.
An analysis of insider ownership at Vaxart Inc. [VXRT]
There are presently around $200 million, or 30.40% of VXRT stock, in the hands of institutional investors. The top three institutional holders of VXRT stocks are: STATE STREET CORP with ownership of 8,486,301, which is approximately -10.15% of the company’s market cap and around 0.60% of the total institutional ownership; VANGUARD GROUP INC, holding 5,477,693 shares of the stock with an approximate value of $34.07 million in VXRT stocks shares; and BLACKROCK INC., currently with $33.7 million in VXRT stock with ownership of nearly 9.751% of the company’s market capitalization.
Positions in Vaxart Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 89 institutional holders increased their position in Vaxart Inc. [NASDAQ:VXRT] by around 5,177,950 shares. Additionally, 66 investors decreased positions by around 8,574,074 shares, while 21 investors held positions by with 18,349,004 shares. The mentioned changes placed institutional holdings at 32,101,028 shares, according to the latest SEC report filing. VXRT stock had 42 new institutional investments in for a total of 1,137,314 shares, while 24 institutional investors sold positions of 4,878,039 shares during the same period.